Page last updated: 2024-09-05

cyanidin 3-galactoside and Cardiovascular Diseases

cyanidin 3-galactoside has been researched along with Cardiovascular Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bolling, BW; Caceres, C; Chun, OK; Hubert, PA; Kim, B; Lee, JY; Lee, SG; Vance, T; Wang, Y; Xie, L1

Trials

1 trial(s) available for cyanidin 3-galactoside and Cardiovascular Diseases

ArticleYear
Aronia berry polyphenol consumption reduces plasma total and low-density lipoprotein cholesterol in former smokers without lowering biomarkers of inflammation and oxidative stress: a randomized controlled trial.
    Nutrition research (New York, N.Y.), 2017, Volume: 37

    Topics: Adult; Anthocyanins; Antioxidants; Biological Availability; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cholesterol; Cholesterol, LDL; Female; Fruit; Galactosides; Humans; Inflammation; Male; Oxidative Stress; Photinia; Plant Extracts; Polyphenols; Smokers; Smoking

2017